How researchers can get a handle on the monkey shortage for tox studies: FDA explains
The FDA on Friday released a new guidance to help researchers deal with the Covid-related challenges of monkey shortages available for conducting nonclinical tox studies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
